Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion DealInvestors Business Daily • 10/31/25
Pfizer has filed a lawsuit seeking to block Novo Nordisk from circumventing Pfizer's deal for weight-loss drug startup MetseraWSJ • 10/31/25
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger AgreementBusiness Wire • 10/31/25
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera AcquisitionBusiness Wire • 10/31/25
Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results?Zacks Investment Research • 10/31/25
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On MetseraInvestors Business Daily • 10/30/25
10 Ideal 'Safer' Dividend Buys From 38 Of 68 October Graham Value All-Stars (GVAS)Seeking Alpha • 10/30/25
What Analyst Projections for Key Metrics Reveal About Pfizer (PFE) Q3 EarningsZacks Investment Research • 10/30/25
Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker.Barrons • 10/30/25
Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer MetseraWSJ • 10/30/25
Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reportsReuters • 10/30/25
Prediction: Putting $1,000 Into These Dividend Stocks Could Pay Off for YearsThe Motley Fool • 10/30/25